Lukas Weiss Selected Research

Lukas Weiss Research Topics

Disease

27	Neoplasms (Cancer) 01/2024 - 04/2009
5	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 01/2019
5	Adenocarcinoma 07/2023 - 09/2019
5	Stomach Neoplasms (Stomach Cancer) 07/2023 - 10/2017
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2018
4	Rectal Neoplasms (Rectal Cancer) 04/2024 - 08/2020
4	Head and Neck Neoplasms (Head and Neck Cancer) 03/2023 - 10/2015
3	Microsatellite Instability 07/2023 - 11/2022
3	Neoplasm Metastasis (Metastasis) 01/2023 - 04/2016
3	Carcinoma (Carcinomatosis) 02/2020 - 12/2015
3	Disease Progression 11/2016 - 04/2009
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2016 - 12/2015
3	Anemia 12/2015 - 12/2013
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2013 - 04/2009
2	Squamous Cell Carcinoma of Head and Neck 03/2023 - 11/2021
2	Breast Neoplasms (Breast Cancer) 02/2020 - 01/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019 - 03/2018
2	Thrombocytopenia (Thrombopenia) 02/2018 - 03/2014
1	Cholangiocarcinoma 01/2023
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	COVID-19 01/2022
1	Oropharyngeal Neoplasms 05/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Merkel Cell Carcinoma 12/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Obesity 01/2019
1	Sarcopenia 01/2019
1	Neurologic Manifestations (Neurological Manifestations) 12/2018
1	Residual Neoplasm 10/2018
1	Hemolysis 10/2018

Drug/Important Bio-Agent (IBA)

6	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2016
6	Biomarkers (Surrogate Marker)IBA 05/2021 - 12/2015
5	Rituximab (Mabthera)FDA Link 01/2019 - 08/2011
3	Circulating Tumor DNAIBA 01/2024 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 12/2021
3	pembrolizumabIBA 03/2023 - 12/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2015
3	Cetuximab (Erbitux)FDA Link 11/2021 - 01/2017
3	Irinotecan (Camptosar)FDA LinkGeneric 04/2021 - 10/2017
3	Fluorouracil (Carac)FDA LinkGeneric 08/2020 - 10/2015
3	Bevacizumab (Avastin)FDA Link 12/2018 - 02/2017
2	B7-H1 AntigenIBA 07/2023 - 08/2020
2	Gemcitabine FDA Link 01/2023 - 01/2023
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 10/2017
2	folfirinoxIBA 01/2023 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2015
2	regorafenibIBA 09/2020 - 01/2019
2	trifluridine tipiracil drug combinationIBA 09/2020 - 01/2019
2	human ERBB2 proteinIBA 03/2020 - 09/2019
2	AntigensIBA 02/2020 - 04/2009
2	C-Reactive ProteinIBA 10/2019 - 12/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2019 - 03/2018
2	CurcuminIBA 01/2019 - 10/2018
2	Temozolomide (Temodar)FDA LinkGeneric 12/2018 - 03/2014
2	Hemoglobins (Hemoglobin)IBA 10/2018 - 12/2015
2	Docetaxel (Taxotere)FDA Link 10/2017 - 10/2015
2	AntibodiesIBA 01/2016 - 12/2015
2	Azacitidine (5 Azacytidine)FDA Link 12/2013 - 08/2011
1	Hematoxylin (Haematoxylon)IBA 04/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 04/2024
1	A 19IBA 01/2024
1	ClaudinsIBA 07/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 07/2023
1	cyclopropapyrroloindoleIBA 03/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	Trinitrotoluene (TNT)IBA 11/2022
1	NivolumabIBA 01/2022
1	SirtuinsIBA 01/2022
1	RamucirumabIBA 04/2021
1	liposomal doxorubicin (Doxil)FDA Link 01/2021
1	olaratumabIBA 01/2021
1	Growth Factor ReceptorsIBA 01/2021
1	Trastuzumab (Herceptin)FDA Link 03/2020
1	PlatinumIBA 03/2020
1	Tumor Biomarkers (Tumor Markers)IBA 02/2020
1	Carcinoembryonic AntigenIBA 02/2020
1	Cell-Free Nucleic AcidsIBA 02/2020
1	O(6)-Methylguanine-DNA MethyltransferaseIBA 01/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 10/2019
1	LigandsIBA 07/2019
1	Programmed Cell Death 1 ReceptorIBA 07/2019
1	Dronabinol (THC)FDA LinkGeneric 01/2019
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2019
1	Valsartan (Vals)FDA Link 01/2019
1	Ramipril (Altace)FDA LinkGeneric 01/2019
1	tetrahydrocurcuminIBA 01/2019
1	Immunoglobulin Variable RegionIBA 10/2018

Therapy/Procedure

15	Therapeutics 07/2023 - 03/2014
14	Drug Therapy (Chemotherapy) 07/2023 - 12/2013
4	Chemoradiotherapy 04/2024 - 03/2014
4	Neoadjuvant Therapy 04/2024 - 08/2020
4	Radiotherapy 11/2022 - 10/2015
2	Immunotherapy 10/2023 - 11/2022
2	Intravenous Infusions 01/2019 - 10/2018
1	Metastasectomy 01/2023
1	Radioimmunotherapy 11/2021
1	Cardiac Resynchronization Therapy 12/2020
1	Adjuvant Radiotherapy 12/2018
1	Palliative Care (Palliative Therapy) 12/2018